LOS ANGELES CAPITAL MANAGEMENT LLC - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q2 2021$59,000
-14.5%
37,165
-5.3%
0.00%
Q1 2021$69,000
-51.7%
39,265
-46.5%
0.00%
-100.0%
Q4 2020$143,000
-18.3%
73,365
+0.1%
0.00%0.0%
Q3 2020$175,000
-28.3%
73,315
-11.8%
0.00%0.0%
Q2 2020$244,000
+225.3%
83,145
+218.1%
0.00%
Q1 2020$75,00026,1350.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital LLC 3,608,171$8,624,0002.44%
Broadfin Capital, LLC 4,226,077$10,100,0001.33%
MORGENS WATERFALL VINTIADIS & CO INC 400,000$956,0000.85%
Consonance Capital Management LP 4,588,352$10,966,0000.81%
Perceptive Advisors 6,521,102$14,542,0000.55%
Diag Capital Management, LP 182,100$435,0000.50%
683 Capital Management, LLC 805,000$1,924,0000.12%
ARDSLEY ADVISORY PARTNERS LP 50,000$120,0000.03%
AVANTAX ADVISORY SERVICES, INC. 65,050$156,0000.03%
PURA VIDA INVESTMENTS, LLC 37,170$89,0000.02%
View complete list of ADMA BIOLOGICS INC shareholders